Canaccord Genuity Remains Sidelined on Sabra Health Care REIT (SBRA) Following Announced Forest Park Dallas Sale
Tweet Send to a Friend
Canaccord Genuity reiterated a Hold rating and $23.00 price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
